Published in Elife on June 17, 2014
Regulation of angiogenesis by aminoacyl-tRNA synthetases. Int J Mol Sci (2014) 0.86
Acetylation promotes TyrRS nuclear translocation to prevent oxidative damage. Proc Natl Acad Sci U S A (2017) 0.81
"...Rewritten in the skin": clues to skin biology and aging from inherited disease. J Invest Dermatol (2015) 0.75
Studying nuclear functions of aminoacyl tRNA synthetases. Methods (2016) 0.75
Large Conformational Changes of Insertion 3 in Human Glycyl-tRNA Synthetase (hGlyRS) during Catalysis. J Biol Chem (2016) 0.75
Competitive binding between Seryl-tRNA synthetase/YY1 complex and NFKB1 at the distal segment results in differential regulation of human vegfa promoter activity during angiogenesis. Nucleic Acids Res (2016) 0.75
Max: a helix-loop-helix zipper protein that forms a sequence-specific DNA-binding complex with Myc. Science (1991) 12.00
The Myc/Max/Mad network and the transcriptional control of cell behavior. Annu Rev Cell Dev Biol (2000) 8.47
Large-scale mapping of human protein-protein interactions by mass spectrometry. Mol Syst Biol (2007) 8.16
Recent progress in the biology and physiology of sirtuins. Nature (2009) 7.73
Identification of 315 genes essential for early zebrafish development. Proc Natl Acad Sci U S A (2004) 5.54
Sirtuin 2 inhibitors rescue alpha-synuclein-mediated toxicity in models of Parkinson's disease. Science (2007) 5.49
The novel ATM-related protein TRRAP is an essential cofactor for the c-Myc and E2F oncoproteins. Cell (1998) 4.52
Binding of myc proteins to canonical and noncanonical DNA sequences. Mol Cell Biol (1993) 4.08
The essential cofactor TRRAP recruits the histone acetyltransferase hGCN5 to c-Myc. Mol Cell Biol (2000) 3.86
Hypoxia-inducible factor 1 and dysregulated c-Myc cooperatively induce vascular endothelial growth factor and metabolic switches hexokinase 2 and pyruvate dehydrogenase kinase 1. Mol Cell Biol (2007) 3.51
Inhibition of SIRT1 catalytic activity increases p53 acetylation but does not alter cell survival following DNA damage. Mol Cell Biol (2006) 3.37
SIRT1 controls endothelial angiogenic functions during vascular growth. Genes Dev (2007) 3.34
c-Myc is essential for vasculogenesis and angiogenesis during development and tumor progression. Genes Dev (2002) 3.16
SirT2 is a histone deacetylase with preference for histone H4 Lys 16 during mitosis. Genes Dev (2006) 3.12
Acetylation-dependent regulation of endothelial Notch signalling by the SIRT1 deacetylase. Nature (2011) 2.47
Structure of the histone deacetylase SIRT2. Nat Struct Biol (2001) 2.37
New functions of aminoacyl-tRNA synthetases beyond translation. Nat Rev Mol Cell Biol (2010) 2.22
The response of autologous T cells to a human melanoma is dominated by mutated neoantigens. Proc Natl Acad Sci U S A (2005) 2.22
Global identification of Myc target genes reveals its direct role in mitochondrial biogenesis and its E-box usage in vivo. PLoS One (2008) 2.12
Function of the c-Myc oncoprotein in chromatin remodeling and transcription. Biochim Biophys Acta (2001) 2.02
Exogenous vascular endothelial growth factor induces malformed and hyperfused vessels during embryonic neovascularization. Proc Natl Acad Sci U S A (1995) 1.88
Role of Mxi1 in ageing organ systems and the regulation of normal and neoplastic growth. Nature (1998) 1.82
Essential nontranslational functions of tRNA synthetases. Nat Chem Biol (2013) 1.72
Proteomics-based identification of differentially expressed genes in human gliomas: down-regulation of SIRT2 gene. Biochem Biophys Res Commun (2003) 1.53
Targeted disruption of the MYC antagonist MAD1 inhibits cell cycle exit during granulocyte differentiation. EMBO J (1998) 1.39
Sequential expression of the MAD family of transcriptional repressors during differentiation and development. Oncogene (1998) 1.27
Unique domain appended to vertebrate tRNA synthetase is essential for vascular development. Nat Commun (2012) 1.24
Genetic evidence for a noncanonical function of seryl-tRNA synthetase in vascular development. Circ Res (2009) 1.23
Myc and Max: molecular evolution of a family of proto-oncogene products and their dimerization partner. Proc Natl Acad Sci U S A (1995) 1.14
The interplay between Mad and Myc in proliferation and differentiation. Trends Cell Biol (2001) 1.14
Noncanonical activity of seryl-tRNA synthetase is involved in vascular development. Circ Res (2009) 1.13
Detection and cloning of a common region of loss of heterozygosity at chromosome 1p in breast cancer. Cancer Res (1995) 1.10
Loss of heterozygosity identifies multiple sites of allelic deletions on chromosome 1 in human male germ cell tumors. Cancer Res (1994) 1.00
Frequent alterations of chromosome 1 in ductal carcinoma in situ of the breast. Oncogene (1995) 0.99
Linkage of prostate cancer susceptibility loci to chromosome 1. Hum Genet (2001) 0.93
Chromosome 1 abnormalities in myeloid malignancies: a literature survey and karyotype-phenotype associations. Eur J Haematol (2009) 0.92
Assembly of b/HLH/z proteins c-Myc, Max, and Mad1 with cognate DNA: importance of protein-protein and protein-DNA interactions. Biochemistry (2005) 0.89
Myc regulates embryonic vascular permeability and remodeling. Circ Res (2009) 0.88
1p13 is the most frequently involved band in structural chromosomal rearrangements in human breast cancer. Genes Chromosomes Cancer (1990) 0.88
Crystal structure of human Seryl-tRNA synthetase and Ser-SA complex reveals a molecular lever specific to higher eukaryotes. Structure (2013) 0.80
Myc and Myb: are the veils beginning to lift? Oncogene (1999) 0.78
The Philadelphia (Ph) chromosome in leukemia. III. Complex Ph translocation plus inversion in chronic myelocytic leukemia. Cancer Genet Cytogenet (1985) 0.77